Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global virus filtration market was valued at USD 4.31 Billion in 2023. It is expected to grow at a CAGR of 11.60% during the forecast period of 2024-2032 and attain a market value of USD 11.57 Billion by 2032. The market growth is driven by the rising incidence of viral contamination in biomanufacturing and the growing focus on quality and safety in healthcare. Patents are focused on advanced technologies such as membrane-based filters, chromatography, nanofiltration, and depth filtration.
The Global Virus Filtration Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for virus filtration include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with virus filtration. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within virus filtration technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for virus filtration technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with virus filtration.
Analysis of Patent Applications
A comprehensive summary of several patent applications which were filed across different jurisdictions for virus filtration and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Analysis of Granted Patents
Detailed analysis of the granted patents across different jurisdictions for virus filtration and their relative value in the IP are covered in the final report.
Virus filtration is a purification technique used to eliminate viral impurities from biological products like therapeutic proteins and vaccines. It makes use of specific filters whose pores are small enough to trap viruses while still letting the right molecules pass through. This procedure guards against viral contamination, ensuring the efficacy and safety of biologics.
The components of virus filtration include filtration systems, kits, reagents, and services. Systems for filtering liquids or gases are used to get rid of undesirable particles, impurities, or microorganisms. To ensure the safety and purity of biological products, virus filtration precisely targets and eliminates viruses from said products.
Technological Advancements in Filtration Techniques is Expected to Boost the Patent Industry Growth
Technological developments in filtration methods improve the precision and efficiency of virus elimination procedures, resulting in safer biopharmaceutical products. Advancements like enhanced membrane materials and nanofiltration techniques lower production costs while boosting virus capture efficiency. For instance, the Ultipor VF Grade DV20 Filter, a novel nanofiber-based filtration product from Pall Corporation improves virus capture while preserving high flow rates. This technological development satisfies manufacturers' demands for more dependable and reasonably priced virus filtration solutions by reflecting the market's emphasis on maximizing filtration performance.
There is an increase in patent activity which focuses on enhancing the performance of virus filtration. There were 12,650 patents granted in 2022. Patents covering these technologies are crucial for companies and thus impact the virus filtration patent landscape.
Increasing Demand for Biopharmaceuticals is Expected to Propel Virus Filtration Patent Industry
Strict virus filtration is required to guarantee product safety and efficacy due to the growing demand for biopharmaceuticals, which include therapeutic proteins and vaccines. In order to comply with regulations and avoid contamination, the market for efficient virus filtration solutions is growing along with the production of biologics.
The report will cover the following sections in detail:
Analysis by Product
Analysis by Application
The breakup based on product includes filtration systems, kits, reagents and services. Viral filtration is an essential step in biological processes that removes viral particles from goods like therapeutic proteins and vaccines. Ensuring that these biologics are devoid of viral contamination preserves their efficacy and safety for use in medicine. Specialized membranes are used in the filtration process to capture viruses while permitting beneficial biological molecules to flow through.
The United States is one of the leading jurisdictions for virus filtration patents, having around 208,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with virus filtration patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the virus filtration field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Genentech Inc.
A biotechnology business that was established in 1976 and has its main office in San Francisco, California, it is a pioneer in the creation and production of biopharmaceuticals. The company uses cutting-edge virus filtration technologies to ensure product safety and specializes in the discovery and production of medications for severe medical conditions. Genentech is renowned for its excellent biologic strategies, especially in the fields of neuroscience, immunology, and oncology.
Other companies include Human Genome Sciences Inc, Radiatric Inc., Biolitec Holding Gmbh & Co Kg, Air Force-Field Systems Llc, Bristol Myers Squibb Co., Novozymes As, F. Hoffmann La Roche, Novartis AG, Amgen Inc, Massachusetts Inst Technology, Dexcom Inc., among others.
The virus filtration patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
Global Zika Virus Therapeutics Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report |
Details |
Analysis by Product |
|
Analysis by Application |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share